seat11a - Publicly Listed Companies: Elevator Pitch, Deep-Dive, Financial Results, and ESG

About seat11a - Publicly Listed Companies: Elevator Pitch, Deep-Dive, Financial Results, and ESG

Investor Insights from CEOs & CFOs | seat11a features CEO interviews, CFO interviews, investor presentations, financial results, earnings presentations, elevator pitches, deep dives and strategy updates from publicly listed companies. Discover clear equity stories, business models, growth strategies, ESG updates, capital markets insights and stock market perspectives for private investors, portfolio managers, analysts and anyone following European stocks, global equities and listed company performance.

Publisher

seat11a.com

Category

business

Language

en

Explicit

No

First episode

28 Jan 2021

Latest episode

1 Oct 2026

Latest episodes

454 episodes in the feed.

1. 

   1 Oct 2026

   wacker EP

   eo

2. 

   16 Sept 2026

   Solutiance AG Elevator Pitch | Smartsourcing, AI & Digital Facility Management

   Solutiance AG Elevator Pitch Presentation In this Elevator Pitch on seat11a, Jonas Enderlein, CEO of Solutiance AG, explains how the company combines technology and physical services to digitalise facility management for owners and operators of real estate portfolios. Digitalising Traditional Facility Management Solutiance addresses a structural weakness in traditional facility management: services and software are typically separated. Conventional service providers perform the required work on site, but analogue processes can result in inefficient workflows, inconsistent service quality and insufficient data. Standalone software can provide a better technological foundation, but requires implementation, training and upfront investment while still depending on users to maintain complete and accurate information. Smartsourcing Model and Facility Scanner Platform Solutiance combines these two worlds through its Smartsourcing model. Its own employees and external service providers work within digital processes supported by Solutiance’s technology and, increasingly, artificial intelligence. At the centre is the company’s Facility Scanner platform, which coordinates workflows and captures the information generated during service delivery. Digital Twin Technology for Real Estate Portfolios As work is performed, Solutiance creates a digital twin of the building for the relevant trade. Property owners therefore receive both the physical service and a continuously developing digital data foundation. This allows customers to monitor service delivery, access asset information and make decisions based on portfolio data rather than relying primarily on manual reporting or incomplete information. Recurring Revenue and Subscription-Based Services The commercial model combines an initial onboarding fee for creating the digital twin with subsequent subscription-based services. According to management, this means that the majority of Solutiance’s revenue is either recurring or returning. Every service performed also leaves a digital trace within Facility Scanner, potentially strengthening the data foundation and customer relationship over time. Scalable Technology Platform and Artificial Intelligence The model is designed to be highly scalable. As Solutiance adds services, it can use the existing technology infrastructure, digital processes, property data and service network across a broader part of the customer’s building portfolio. AI provides another potential efficiency lever as more workflows become automated or digitally supported. Long-Term Vision for Full-Service Property Coverage The company’s longer-term vision is particularly important to the equity story: Solutiance intends to continuously expand its service portfolio until it can provide full-service property coverage, effectively enabling customers to operate complete buildings through Solutiance’s technology and service ecosystem. ▶️ Other videos: Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/ Company Presentation: https://seat11a.com/investor-relations-company-presentation/ Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/ Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/ ESG Presentation: https://seat11a.com/investor-relations-esg/ T&C This publication is for informational purposes only and does not constitute investment advice. By using seat11a.com, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

3. 

   12 Sept 2026

   BRAIN Biotech AG Financial Results 9M 2025 / 26 | Enzymes, BioIncubator & Outlook

   BRAIN Biotech AG 9M 2025/26: Key Takeaways In this Financial Results presentation on seat11a, Michael Schneiders, CFO of BRAIN Biotech AG, presents the company’s 9M FY 2025/26 Financial Results and discusses the performance of BRAINBiocatalysts and BRAINBioIncubator, profitability, cash flow, financing, the upcoming CEO transition and the updated full-year outlook. 9M FY 2025/26 Revenue and Segment Performance BRAIN Biotech generated revenue of €34.6 million during the first nine months of FY 2025/26, representing a decline of 10.5% year-on-year. The development primarily reflects weaker performance in BRAINBiocatalysts, where revenue declined 13.3% to €30.8 million. BRAINBioIncubator developed in the opposite direction, increasing revenue 21% to €3.9 million as the company continued to realise value from its innovation portfolio. BRAINBiocatalysts and Enzyme Business Development During Q3, BRAINBiocatalysts revenue was sequentially stable compared with Q2 but remained below the prior-year period. Management attributes the weaker development to a high comparison base, subdued demand for baking enzymes and initial operational challenges at the new Netherlands production facility. The enzyme-related contract research business, however, remained solid and is expected to continue performing well through the remainder of the financial year. Adjusted EBITDA and BRAINBioIncubator Milestones Adjusted Group EBITDA amounted to minus €0.7 million for the nine-month period. Management continues to focus on cost control, including lower headcount, while BRAINBioIncubator milestone income is increasingly contributing to Group performance. The BioIncubator recorded a €1 million Pharvaris-related milestone during the first nine months, with another €1 million expected to be recognised in Q4. The FDA acceptance of the NDA for deucrictibant represents another important development within the portfolio. Financing, Cash Flow and Netherlands Production Investment The Group has also strengthened its financing position. BRAIN secured a €9 million revolving credit line, while an additional €11.51 million Royalty Pharma milestone was received in Q4. Operating cash flow improved substantially year-on-year to minus €3.6 million, while investment in the new Netherlands production site was largely completed during Q3. CEO Transition to Dr. Sven K. Weber BRAIN is simultaneously preparing for a management transition. Dr. Sven K. Weber will become CEO on 1 October 2026, succeeding Adriaan Moelker. Weber brings significant experience in enzymes and will take over as BRAIN continues to pursue its long-term strategy of profitable specialty-enzyme growth and its ambition to become one of the world’s top-ten global enzyme companies. Updated FY 2025/26 Guidance Following the weaker development of BRAINBiocatalysts, management adjusted its FY 2025/26 segment guidance. Biocatalysts revenue is now expected to be below the previous financial year’s level and the adjusted EBITDA margin below the previously anticipated level of around 10%. Conversely, BRAINBioIncubator guidance was raised, with revenue now expected at approximately €6 million and adjusted EBITDA above €1 million. Adjusted Group EBITDA is still expected to be around break-even for the full year. ▶️ Other videos: Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/ Company Presentation: https://seat11a.com/investor-relations-company-presentation/ Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/ Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/ ESG Presentation: https://seat11a.com/investor-relations-esg/ T&C This publication is for informational purposes only and does not constitute investment advice. By using seat11a.com, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

Who has been a guest on seat11a - Publicly Listed Companies: Elevator Pitch, Deep-Dive, Financial Results, and ESG

Names identified in recent episode analyses. Showing up to five guests.

• Christoph Dieterle
• Clemens Billek
• Michael Schneiders
• Romy Acosta
• Ronald Slabke

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Spotify

5.0 / 5

3 ratings

Podcast Authority Score: 61 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality

99

Social presence

0

YouTube

0

Engagement

60

Contact seat11a - Publicly Listed Companies: Elevator Pitch, Deep-Dive, Financial Results, and ESG

Guest appearances

Books guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.

Questions about seat11a - Publicly Listed Companies: Elevator Pitch, Deep-Dive, Financial Results, and ESG